PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
06-Jan-2022 Western Blotting Market by Product, Application, End User and Region - Global Forecast to 2026 - ResearchAndMarkets.com Businesswire
06-Jan-2022 n-Lorem Foundation Notes Latest in Guidance From FDA on Developing ASO Drug Products for Patients With Nano-rare Diseases Businesswire
06-Jan-2022 Worldwide Probiotics Food & Cosmetics Industry to 2026 - Featuring Nestle, Danone and General Mills Among Others - ResearchAndMarkets.com Businesswire
06-Jan-2022 PharmaCyte Biotech to Present at H.C. Wainwright BioConnect Conference Businesswire
06-Jan-2022 Clear Creek Bio Advances Its Highly Potent SARS-CoV-2 PLpro Inhibitors in Discovery of an Oral Direct-Acting Antiviral to Treat COVID-19 Businesswire
06-Jan-2022 Amgen and Generate Biomedicines Announce Multi-Target, Multi-Modality Research Collaboration Agreement Businesswire
06-Jan-2022 Alison Johnson Rejoins Wilson Sonsini’s Corporate Practice Businesswire
06-Jan-2022 Global Osteoporosis Drugs (Bisphosphonates, Selective Estrogen Inhibitors Modulator (SERM), Others) Markets, Forecasts & Opportunities, 2021-2026 - ResearchAndMarkets.com Businesswire
06-Jan-2022 Infinity to Present at 40th Annual J.P. Morgan Healthcare Conference Businesswire
06-Jan-2022 NanoVibronix Further Expands VA Distribution Network to Include SDVOSB Delta Medical, LLC Businesswire
06-Jan-2022 Jnana Therapeutics to Present at 40th Annual J.P. Morgan Healthcare Conference Businesswire
06-Jan-2022 RTW Investments Bolsters Leadership Team With Key Executive Appointments Businesswire
06-Jan-2022 Global Furfuryl Alcohol Market (2021 to 2028) - Featuring Illovo Sugar Africa, Lenzing and Behran Oil Among Others - ResearchAndMarkets.com Businesswire
06-Jan-2022 Melinta Therapeutics President and CEO Christine Ann Miller Elected to Board of Directors of Iveric Bio Businesswire
06-Jan-2022 TRexBio Announces Collaboration with Janssen to Discover Novel Targets for Immunology and Inflammation Businesswire
06-Jan-2022 Otsuka and Lundbeck Announce FDA Approval of Supplemental New Drug Application for REXULTI® (brexpiprazole) to Treat Schizophrenia in Pediatric Patients Ages 13-17 Businesswire
06-Jan-2022 Aldeyra Therapeutics to Participate in Fireside Chat at the H.C. Wainwright BioConnect Virtual Conference Businesswire
06-Jan-2022 i2O Therapeutics Announces Research Collaboration and Option Agreement with Janssen to Investigate the Oral Delivery of Macromolecules Businesswire
06-Jan-2022 Bluestar Genomics Announces Plans to Present at the 40th Annual J.P. Morgan Healthcare Conference January 12 at 4:30 p.m. Eastern Time Businesswire
06-Jan-2022 Exelixis and Iconic Therapeutics Amend Option and License Agreement for XB002, an Antibody-Drug Conjugate Targeting Tissue Factor Businesswire